跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
藥學系
臺北醫學大學
藥學院
電話
+886-2-27361661#6192 +886-2-27361661#6193
電子郵件
pharmacy@tmu.edu.tw
網站
http://pharmschool.tmu.edu.tw/
郵寄地址
在地圖上顯示
No. 250 Wu-Xing Street
11031
Taipei
概覽
指紋
網路
專家檔案
(36)
專案
(474)
研究成果
(1674)
資料集
(85)
指紋
查看啟用 藥學系 的研究主題。這些主題標籤來自此機構會員的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine & Life Sciences
Taiwan
100%
Histone Deacetylase Inhibitors
78%
Neoplasms
66%
Inhibitory Concentration 50
53%
In Vitro Techniques
52%
Apoptosis
50%
Pharmaceutical Preparations
40%
Growth
40%
Histone Deacetylases
40%
Population
40%
Proteins
39%
Cell Line
36%
Therapeutics
36%
Anti-Inflammatory Agents
33%
Lipopolysaccharides
33%
High Pressure Liquid Chromatography
33%
Pharmacokinetics
32%
Cohort Studies
32%
Antioxidants
31%
Mucocutaneous Lymph Node Syndrome
30%
Antineoplastic Agents
30%
Colorectal Neoplasms
29%
Cyclooxygenase 2
28%
Breast Neoplasms
28%
Genes
27%
Acids
25%
Tubulin
24%
isosteviol
24%
Water
24%
Non-Small Cell Lung Carcinoma
24%
Tubulin Modulators
23%
Down-Regulation
23%
Nanoparticles
22%
Nitric Oxide
22%
Micelles
22%
Gene Expression
22%
Macrophages
21%
Cell Movement
21%
Drug Delivery Systems
21%
Resveratrol
21%
Phosphorylation
21%
Ethanol
21%
Autophagy
21%
Biological Availability
20%
Pharmacists
20%
Xanthine Oxidase
20%
Cell Proliferation
20%
aristolochic acid I
20%
Heterografts
20%
Inflammation
20%
Colonic Neoplasms
20%
Lung Neoplasms
19%
Rabbits
19%
Lignans
19%
Microtubules
19%
osthol
19%
Pyruvaldehyde
19%
Nitric Oxide Synthase Type II
18%
Databases
17%
Mass Spectrometry
17%
Lactic Acid
17%
Kidney
17%
indoline
17%
Cell Death
17%
Dinoprostone
17%
Serum
16%
Interleukin-1
16%
Single Nucleotide Polymorphism
16%
Diterpenes
16%
Reactive Oxygen Species
16%
3-(1-benzenesulfonyl-2,3-dihydro-1H-indol-5-yl)-N-hydroxyacrylamide
16%
Liquid Chromatography
16%
Glycosides
15%
Alzheimer Disease
15%
Solubility
15%
Hydrolyzable Tannins
15%
Hydroxamic Acids
15%
Histone Deacetylase 6
15%
Confidence Intervals
15%
Neoplasm Metastasis
15%
Acetylation
15%
Osteoporosis
15%
Prescriptions
15%
Enzymes
15%
Antrodia
15%
benzenesulfonamide
15%
Hepatocellular Carcinoma
14%
Liver
14%
Prostatic Neoplasms
14%
Vorinostat
14%
Chinese Traditional Medicine
14%
Wounds and Injuries
14%
Messenger RNA
14%
Matrix Metalloproteinases
14%
Glioblastoma
14%
Tablets
14%
hispidulin
14%
Safety
14%
Structure-Activity Relationship
14%
A549 Cells
14%
Chemical Compounds
Drug
60%
Protein
58%
Histone
52%
Antiproliferative
39%
Antiinflammatory
30%
Antioxidant Agent
29%
Antitumor
26%
Antineoplastic Agent
25%
Pharmacokinetics
25%
Plasma
24%
Bioavailability
23%
Nitric Oxide
22%
Metabolite
22%
Dose
20%
Apoptotic
19%
Leaf Like Crystal
19%
Aristolochic Acid
18%
Application
18%
Genetic Polymorphism
18%
Percutaneous
18%
Hydroxamic Acid
17%
Acid
17%
High-Pressure Liquid Chromatography
16%
Lipopolysaccharide
15%
Lignan
15%
Flavonoid
14%
Nanoparticle
14%
Cell Death
14%
Methylglyoxal
14%
Bioactivity
14%
Oxidative Stress
14%
50 Percent Growth Inhibition
13%
Metabolic
13%
Composite Material
13%
Cantharidin
13%
Glycoside
13%
Marker
13%
Disorder
13%
Micelle
12%
Resistance
12%
Reactive Oxygen Metabolite
12%
Amount
12%
Ethanol
12%
Polymerization Reaction
12%
Free Radical
12%
Resveratrol
12%
Modification
12%
Structure-Activity Relationship
12%
Column Like Crystal
11%
Protective
11%
Hydrolysable Tannin
11%
Quercetin
11%
Colchicine
11%
Collagen
11%
Shikonin
11%
Dissolution
11%
Solubility
10%
Nanocarrier
10%
Lipid
10%
Cell Viability
10%
3-Hydroxybutyrate
10%
Pharmacological Metabolism
10%
Tannin
9%
Alkannin
9%
Hydrogel
9%
Retinal
9%
Glucose
9%
Chitosan
9%
Enantiomer
9%
Microcrystallinity
9%
Prostaglandin E2
9%
Time
9%
Western Blotting
9%
Granulation
9%
Weight
9%
Succinate
9%
Osthole
9%
Superoxide
9%
Vascular Targeting Agent
9%
Calcium(0)
9%
Simulation
9%
Biological Marker
8%
Safety
8%
Peptide
8%
Liquid Film
8%
Diterpenoid
8%
Antiacne
8%
Poly(ethylene Glycol)
8%
Liquid
8%
Polysaccharide
8%
Sildenafil
8%
Prostaglandin E1
8%
Nifedipine
8%
Wogonin
8%
Ethyl Acetate
8%
Food
8%
Acetylation
8%
Fenofibrate
8%
Liquid Chromatography
8%